Bartlett & Co’s Zivo Bioscience ZIVO Stock Holding History
Bought
Maintained
Sold
Other funds holding ZIVO
Bartlett & Co's ZIVO Position: Q4 2023 in Review
Bartlett & Co reduced its Zivo Bioscience (ZIVO) stake by 0.6% in Q4 2023, selling an estimated $3 and leaving 166 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1264.
Bartlett & Co first reported a position in ZIVO in Q2 2021 and has held it in 10 quarters since. The position peaked at $5K in Q3 2021. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.
- Bartlett & Co held 166 shares of Zivo Bioscience worth $0 as of Q4 2023.
- Bartlett & Co sold 1 Zivo Bioscience share in Q4 2023, an estimated $3.
- Zivo Bioscience made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1264 holding.
- Bartlett & Co first reported a position in Zivo Bioscience in Q2 2021 and has held it in 10 quarters since.
- Bartlett & Co's Zivo Bioscience position peaked at $5K in Q3 2021.
- 2 funds tracked by Wall St. Rank held Zivo Bioscience as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.